🇺🇸 FDA
Pipeline program

DR-2001a

DR-DZL-201

Phase 2 small_molecule completed

Quick answer

DR-2001a for Endometriosis is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Endometriosis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials